ACV-1

N/A

Report date: 2022/02/21 10:59:49

Base Information

Drug NameACV-1
Drug Alias NameACV-1Vc-1.1AVC-6.8
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionBeta-4 nicotinic acetylcholine receptor agonistsNeuronal acetylcholine receptor; alpha9/alpha10 antagonists
TargetsNeuronal acetylcholine receptor; alpha9/alpha10Beta-4 nicotinic acetylcholine receptor
Therapy Area/IndicationsNeuralgia, PostherpeticNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Melbourne
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeuralgia, PostherpeticNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A